ROCHE-WA18063

Study Sponsor : Roche

Study Title

A randomized, double-blind study of the effect of tocilizumab on reduction in signs and symptoms in patients with moderate to severe active rheumatoid arthritis and inadequate response to DMARD therapy

Medicine or Vaccine (generic name)

tocilizumab

Sponsor Identification Number

WA18063

Trial Registry Identification Number(#'s)

NCT00106574

Medical Condition

rheumatoid arthritis

Phase

Phase 3

Link to study details on the Roche Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/ct2/show/NCT00106574?term=WA18063&rank=2

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

January 2014